Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Ascent Pharmaceuticals, Inc.: Hydrocodone Bitartrate and Acetaminophen Recalled for Foreign Tablet Presence

Agency Publication Date: November 17, 2020
Share:
Sign in to monitor this recall

Summary

Ascent Pharmaceuticals is recalling 9,768 bottles of Hydrocodone Bitartrate and Acetaminophen (10mg/325mg) because a bottle was found to contain a different medication, Losartan Potassium (100 mg). This recall affects 100-count bottles of the prescription pain reliever manufactured for Camber Pharmaceuticals. Consumers should contact their healthcare provider or pharmacist immediately to determine if their medication is affected. Return any unused tablets to the pharmacy for a refund and contact the manufacturer for further instructions.

Risk

Taking an incorrect medication like Losartan Potassium (a blood pressure drug) instead of the intended Hydrocodone pain reliever could lead to unintended side effects or lack of pain management. There is a risk of dangerous drug interactions or severe health consequences if the wrong medication is consumed.

What You Should Do

  1. Check your prescription bottle for 'Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg' in 100-count bottles with NDC 31722-943-01.
  2. Verify the bottle's Lot Number and Expiration Date: look for Lot # 20070518 with an Expiration Date of June 2022.
  3. If your bottle matches this lot number, contact your healthcare provider or pharmacist immediately for guidance on how to safely proceed and to obtain a replacement.
  4. Return any unused product from the affected lot to the pharmacy where it was purchased for a refund.
  5. Contact Ascent Pharmaceuticals, Inc. or Camber Pharmaceuticals for further instructions regarding this recall.
  6. For additional questions or to report a problem, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund

Healthcare provider consultation and pharmacy refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg (100-count bottle)
Model:
NDC 31722-943-01
Recall #: D-0097-2021
Lot Numbers:
20070518 (Exp. June 2022)
Date Ranges: June 2022

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 86665
Status: Resolved
Manufacturer: Ascent Pharmaceuticals, Inc.
Sold By: Camber Pharmaceuticals, Inc.; Pharmacies nationwide
Manufactured In: United States
Units Affected: 9768 Bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.